Sequifenadine manufacturers
- Sequifenadine
-
- $2140.00
-
2026-05-11
- CAS:57734-69-7
- Purity:
- Supply Ability: 10g
|
| | Sequifenadine Basic information |
| Product Name: | Sequifenadine | | Synonyms: | Xynclydyl-3-di(o-tolyl)carbynol;α,α-Bis(2-methylphenyl)-1-azabicyclo[2.2.2]octane-3-methanol;α,α-Bis(2-methylphenyl)-3-quinuclidinemethanol;1-azabicyclo[2.2.2]octan-3-yl-bis(2-methylphenyl)methanol;Sequifenadine;bicarphene;1-Azabicyclo[2.2.2]octane-3-methanol, α,α-bis(2-methylphenyl)- | | CAS: | 57734-69-7 | | MF: | C22H27NO | | MW: | 321.46 | | EINECS: | | | Product Categories: | | | Mol File: | 57734-69-7.mol |  |
| | Sequifenadine Chemical Properties |
| Melting point | 238-240 °C | | Boiling point | 455.0±40.0 °C(Predicted) | | density | 1.14±0.1 g/cm3(Predicted) | | pka | 13.28±0.29(Predicted) |
| | Sequifenadine Usage And Synthesis |
| Uses | Sequifenadine is a H1-antihistamine. Sequifenadine has the potential for the research of inflammatory eye disease with allergic symptoms[1][2]. | | References | [1] Bukovskis, Maris, et al. H1-antihistamines suppress wheal-and-flare reaction and skin blood perfusion measured by laser doppler flowmetry: randomized, double-blind, placebo-controlled, crossover design study.
[2] Ophthalmic drops for treatment of inflammatory eye disease with allergic symptoms. Patent RU2156128C1. |
| | Sequifenadine Preparation Products And Raw materials |
|